US3075527A - Sterile medicated strips - Google Patents
Sterile medicated strips Download PDFInfo
- Publication number
- US3075527A US3075527A US33510A US3351060A US3075527A US 3075527 A US3075527 A US 3075527A US 33510 A US33510 A US 33510A US 3351060 A US3351060 A US 3351060A US 3075527 A US3075527 A US 3075527A
- Authority
- US
- United States
- Prior art keywords
- medicament
- strip
- eye
- tears
- impregnated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 claims description 56
- 239000000243 solution Substances 0.000 description 16
- 230000002745 absorbent Effects 0.000 description 10
- 239000002250 absorbent Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000005470 impregnation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000002966 varnish Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 3
- 229960002028 atropine sulfate Drugs 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- VPJXQGSRWJZDOB-UHFFFAOYSA-O 2-carbamoyloxyethyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCOC(N)=O VPJXQGSRWJZDOB-UHFFFAOYSA-O 0.000 description 2
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 2
- DWSGTFTVBLXELC-MOTQWOLNSA-N hydron;[(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2-hydroxy-2-phenylacetate;bromide Chemical compound Br.C([C@H]1CC[C@@H](C2)N1C)C2OC(=O)C(O)C1=CC=CC=C1 DWSGTFTVBLXELC-MOTQWOLNSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- HZOTZTANVBDFOF-PBCQUBLHSA-N physostigmine salicylate Chemical compound OC(=O)C1=CC=CC=C1O.C12=CC(OC(=O)NC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C HZOTZTANVBDFOF-PBCQUBLHSA-N 0.000 description 2
- RNAICSBVACLLGM-GNAZCLTHSA-N pilocarpine hydrochloride Chemical compound Cl.C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C RNAICSBVACLLGM-GNAZCLTHSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
Definitions
- an ophthalmic applicator which in its preferred form is an elongated, flat strip of soft fabric, a part of which is impregnated with a dry medicament miscible with tears.
- a preferred method of making the applicator is to apply a suitable quantity of a medicament solution of selected concentration to a soft textured, bibulous filter paper, dry it in warm air, seal it in an envelope, and sterilize it.
- the absorbent strip is varnished at one end and the medicament is applied only to the other. The varnish is dried before the medicament is applied.
- the medicament is applied as a solution of selected strength to the unvarnished part of the strip and the solution is dried leaving the paper impregnated with dry medicament.
- the medicament used is preferably of such nature that it is soluble in tears and in such common solvents as water or alcohol.
- These small strips, for instance 2" long x wide may have rounded and noticed ends and may be packaged in small polyethylene envelopes and sterilized. Sterilization is preferably done by the ethylene oxide method, as described in my copending application Serial No. 679,196 now Patent No. 3,032,182.
- Example I The paper to be used in preparing these medications is a highly absorbent, soft textured, bibulous filter paper which is varnished on both sides almost to the tip to prevent the distribution of the introduced solution throughout its length by capillary action.
- the varnish may be of any type but especially of neutral, quick drying resinous type, such as Bakelite. This paper then is die-cut to a narrow strip which is notched on one end.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
Jan; 29', 1963 A. w. BECHTOLD ,0
STERILE MEDICATED STRIPS Filed June 2, 1960 IMPREGNATED, NOTCHED END VARNISHED END IN V EN TOR.
ARTHUR W. BECHTOLD 3am Ma ATTORN S 3,075,527 STERILE MEDIQATED STRIPS Arthur W. Bechtold, Isiip, N.Y., assignor, by mesne assignments, to Chernway Corporation, Wayne, N.J., a corporation of Delaware Filed dune 2, 1969, Ser. No. 33,510 7 Claims. (Cl. 12826t This invention relates to the treatment of the eyes and particularly to a new carrier of medicament, to a method of making it, and to a novel method of introducing a medicament to the eye. The invention is particularly useful when it is desired to introduce to the eye a very small quantity of medicament, for instance less than one drop.
One object of this invention is to prepare medicaments in a sterile, solid form adapted to immediate use.
Another object is to provide medicated applicators which require no instruments for application.
Another object is to avoid the use of liquid in the treatment of the eye.
Another object is to prepare a novel applicator for ophthalmic medicaments soluble in tears.
Another object is to apply dry medicaments to the eye in the treatment of ophthalmic diseases.
The standard method of applying medicament to the eye is to use a dropper. This requires a bottle for the medicament, a stopper which is handled, a dropper, a container for the dropper and sometimes a sterilizer or a sterilizing solution for the sterilization of the dropper. The use of the dropper is not altogether satisfactory when very small quantities or" medicament are to be applied, for instance less medicament than would be included in one or two drops. In some cases the carrier liquid is irritating and it is desirable to apply the medicament in a dry state. After a bottle is opened, the contents are sometimes regarded as not sterile, resulting in the loss of expensive medicament.
The objects of the invention are accomplished, generally speaking, by an ophthalmic applicator which in its preferred form is an elongated, flat strip of soft fabric, a part of which is impregnated with a dry medicament miscible with tears. A preferred method of making the applicator is to apply a suitable quantity of a medicament solution of selected concentration to a soft textured, bibulous filter paper, dry it in warm air, seal it in an envelope, and sterilize it. In preferred cases the absorbent strip is varnished at one end and the medicament is applied only to the other. The varnish is dried before the medicament is applied. The medicament is applied as a solution of selected strength to the unvarnished part of the strip and the solution is dried leaving the paper impregnated with dry medicament. The medicament used is preferably of such nature that it is soluble in tears and in such common solvents as water or alcohol. After the strip has been dried it is cut by sterile means into small strips, each of which includes a quantity certain of medicament, for instance the dried content of one, two or more drops. These small strips, for instance 2" long x wide may have rounded and noticed ends and may be packaged in small polyethylene envelopes and sterilized. Sterilization is preferably done by the ethylene oxide method, as described in my copending application Serial No. 679,196 now Patent No. 3,032,182.
Example I.The paper to be used in preparing these medications is a highly absorbent, soft textured, bibulous filter paper which is varnished on both sides almost to the tip to prevent the distribution of the introduced solution throughout its length by capillary action. The varnish may be of any type but especially of neutral, quick drying resinous type, such as Bakelite. This paper then is die-cut to a narrow strip which is notched on one end.
I 3,075,527 Patented Jan. 29, 1963 The absorbent end is exposed to one drop of medication for instance containing .125 mg. of tetracaine hydrochloride, introduced by either a mechanized syringe capable of dispensing one drop at a time, pipetting manually, or dipping in a solution. The strips are dried in warm air-current and packaged individually in a transparent bag such as described in my copending case which would admit and maintain sterility. The ready strip is sterilized in ethylene oxide. Materials other than paper, that have absorbing qualities, may be used instead of paper strips i.e. gauze, and fabrics but they should be lintless and soft.
In use a sterile package containing a medicated strip is opened, the medicated strip is taken by its varnished end, and the soft, medicament-impregnated end of the strip is tucked inside the eyelid, for instance inside the lower lid where the medicament, being soluble in tears, is absorbed and distributed by the tears of the eye to the places which require treatment.
Typical of the medicaments which can be applied in this Way are homatropine HBr, atropine sulfate, pilocarpine HCl, eserine salicylate, carbamylcholine chloride, and tetracaine HCl.
In place of the filter paper there can be used any soft absorbent material, that is to say, any material which is acceptable to the eye without too much irritation, which will absorb an adequate quantity of medicament solution such as soft cotton or linen fabrics, and synthetics such as woven strands of inert plastic threads. The shape of the applicator can be as desired being rounded, notched, or any other convenient shape at the end which is to be inserted in the eye. It is unnecessary to varnish the strip although varnish, or a high size, or lacquering has the advantage of limiting the penetration of the medicament solution into the paper and of preventing moisture on the hands of the physician from travelling through the fabric to the medicated end. impregnation by means of water solution of the drug is satisfactory, but alcoholic solutions may also be used for impregnation and have the advantage of drying faster.
In some instances it is desirable to include in the solution a small amount of visible indicator, examples of which are rose bengal and fiuorescein sodium, so that the physicians may be able to estimate how much of the medicine will be absorbed by tears. By observing the color of the tears as they dissolve the medicine a reasonable estimation can be made of the quantity of medicine which has been taken. In what may be considered standard practice, it is satisfactory to include up to 3 mg. of such dyes in the impregnated end of the strip.
In impregnating as in Example I one may assume that 20 drops equal 1 cc. and make up solutions that contain in one drop the following quantities of medicament.
Amt. Percent Present,
One Drop 525 include in a solution that quantity of the desired medicament which will deposit the quantity of medicament desired in the applicator.
Example II.A paper strip 1 /2 wide, 1 long and made of soft filter paper was varnished on both sides except for a strip Wide along one long edge. A solution of atropine sulfate was made up to contain 0.125 mg. of medicament per drop. Drops of the solution were placed 4 apart on the exposed edge of the filter paper and allowed to dry in warm air. The strip was cut apart between the drops producing 48 small strips each of which contained about 0.125 mg. of the medicament. Each of these small strips was placed in a small envelope of polyethylene which was sealed thereafter. The sealed strips were placed in the autoclave which was closed and filled with ethylene oxide in a non-explosive concentration. The ethylene oxide penetrated the polyethylene envelope and sterilized the contents. In using the strip the doctor opened the envelope at the varnished end of the strip, removed the strip from the envelope, and immersed it in the tears of the eye gathered in the lower lid. The medicament, being soluble in tears was dissolved out of the strip and carried throughout the eye.
Air drying was used in drying the impregnated paper in this example, but in general drying will be carried out at elevated temperatures under reasonably sterile conditions. Absolute sterilization of impregnation and drying is not necessary where the strips are to be sterilized after packaging. In some cases, where it is desirable to have greater concentrations of medicament than can readily be applied in a single drop, repeated impregnations and dryings may be resorted to. Where a greater concentration of medicament is desired in the tears than can be obtained from a single strip, the physician can apply more than one strip.
In each instance the envelope containing the applicator strip will be labeled with the name and quantity oi medicament carried.
The advantages of the invention are in the accomplishving of the objectives of the invention. There are other advantages, for instance over the application of medicaments by the dropper. The quantity of liquid which the eye can retain is small and the addition of more than that limited quantity achieves no purpose, but material variations in the quantity of medicines usefully employable in the eye can be achieved by dissolving the medicine from more than one strip into the tears of the eye, thus increasing the concentration.
The necessity of keeping bottles of solutions at various strengths is. avoided. Also, the danger of breakage and spillage is lessened. Furthermore, the use of a medicament in liquid form increases the volume of fiuid in the eye causing the excess liquid to flow out of the eye and the medicament, already diluted in liquid form; is further diluted in its concentration when it is inserted into the eye fluids. This invention avoids all these problems he cause the medicament in the concentrated dry form utilizes the eye fluids to form the medicament in concentrated liquid form. There is thus no increase in the amount of fluid in the eye to cause the eye fluids to overflow and there is no dilution of the medicament concentration by the eye fluids themselves.
The accompanying drawing is a diagrammatic representation of a notched strip of filter paper one end of which has been varnished and the other impregnated with a quantity of medicament.
As many apparently widely different embodiments of the present invention may be made without departing from the spirit and scope thereof, it is to be understood that the invention is not limited to the specific embodimerits.
What is claimed is:
1. A medicated ophthalmic applicator comprising an elongated, fiat, thin, absorbent, soft, bibulous filter paper strip having a portion shaped for admission to the eye and impregnated with a dry ophthalmic medicament miscible with tears.
2. The applicator of claim 1 in which the impregnated portion of the strip also contains an indicator.
3. The applicator of claim 1 in which the ophthalmic medicament is selected from the group consisting of homatropine HBr, atropine sulfate, pilocarpine HCl, Eserine salicylate, carbamylcholine chloride, and tetra came.
4. The applicator of claim 1 in which the impregnated portion of the strip carries the ophthalmic medicament in an amount equivalent to about 0.125 to 2 mg. of the medicament.
5. A medicated ophthalmic applicator comprising an elongated, flat, thin, absorbent, soft, bibulous filter paper strip having a stifiened, non-absorbent portion convenient for handling, and an absorbent portion shaped for admission to the eye impregnated with a dry ophthalmic medicament miscible with tears.
6. A medicated ophthalmic applicator comprising an elongated, fiat, thin, absorbent, soft, bibulous filter paper strip having a rounded and notched portion for admission to the eye impregnated with a dry ophthalmic medicament miscible with tears.
7. A medicated ophthalmic applicator comprising an elongated, flat, thin, absorbent, soft, bibulous filter paper strip varnished throughout a substantial port of its length, and a rounded and notched unvarnished part for admission to the eye impregnated with a dry medicament miscible with tears.
References fitted in the file of this patent UNITED. STATES PATENTS 1,687,472 Dorman et a1. Oct. 9, 1928 2,702,780 Lerner Feb. 22, 1955 2 ,703,777 Feinstein et a1. Mar. 8, 1955
Claims (1)
1. A MEDICATED OPHTHALMIC APPLICATOR COMPRISING AN ELONGATED, FLAT SOFT, BIBULOUS FILETR PAPER STRIP HAVING A PORTION SHAPED FOR ADMISSION TO THE EYE AND IMPREGNATED WITH DRY OPHTHALMIC MEDICAMENT MISCIBLE WITH TEARS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33510A US3075527A (en) | 1960-06-02 | 1960-06-02 | Sterile medicated strips |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33510A US3075527A (en) | 1960-06-02 | 1960-06-02 | Sterile medicated strips |
Publications (1)
Publication Number | Publication Date |
---|---|
US3075527A true US3075527A (en) | 1963-01-29 |
Family
ID=21870808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US33510A Expired - Lifetime US3075527A (en) | 1960-06-02 | 1960-06-02 | Sterile medicated strips |
Country Status (1)
Country | Link |
---|---|
US (1) | US3075527A (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3678151A (en) * | 1969-07-25 | 1972-07-18 | Gugol Clini Tex Inc | Biological staining method |
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US3863633A (en) * | 1971-06-04 | 1975-02-04 | Pharmacia Ab | Composition containing a substance showing a topical effect on the eye, and a method of preparing the same |
US3870791A (en) * | 1972-04-24 | 1975-03-11 | Heskel M Haddad | Solid state ophthalmic medication delivery method |
US4540408A (en) * | 1981-04-30 | 1985-09-10 | Smith And Nephew Associated Companies Limited | Applicators for pharmacologically active agents, their preparation and use |
US4778457A (en) * | 1986-11-06 | 1988-10-18 | York Kenneth K | Disposable applicator |
US5928662A (en) * | 1996-07-31 | 1999-07-27 | Phillips; Andrew F. | Ocular drug delivery device |
WO2000069506A1 (en) * | 1999-05-18 | 2000-11-23 | Ocular Research Of Boston, Inc. | Method for instilling a controlled dose of fluid into the eye |
EP1104263A1 (en) * | 1998-08-12 | 2001-06-06 | Ocular Research of Boston, Inc. | Measurement of tear film break-up-time |
EP1332754A1 (en) * | 2002-01-31 | 2003-08-06 | Daniel Mojon | Material-releasing carrier |
US20030225381A1 (en) * | 2002-05-30 | 2003-12-04 | Van Dalen Johan T.W. | Apparatus and method for delivering controlled quantities of one or more agents to the eye |
EP1407732A1 (en) * | 2002-10-08 | 2004-04-14 | Michael Dr. Horstmann | Eye applicable device for secure dosage of systemic and topic medication |
US9320645B2 (en) | 2013-05-29 | 2016-04-26 | Terry Glasser | Approach to administering ocular medication |
US9510972B2 (en) | 2012-01-04 | 2016-12-06 | Sight Sciences, Inc. | Dry eye treatment systems |
US9724230B2 (en) * | 2012-01-04 | 2017-08-08 | Sight Sciences, Inc. | Dry eye treatment apparatus and methods |
WO2018017873A1 (en) | 2016-07-20 | 2018-01-25 | Ryan Edwin | Eye drop applicator and method |
JP2018518514A (en) * | 2015-06-26 | 2018-07-12 | コンティプロ アクチオヴァ スポレチノスト | Ophthalmic pharmaceutical composition |
US10414832B2 (en) | 2015-06-26 | 2019-09-17 | Contipro A.S | Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof |
US10617711B2 (en) | 2014-06-30 | 2020-04-14 | Contipro A.S. | Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof |
US10618984B2 (en) | 2016-06-27 | 2020-04-14 | Contipro A.S. | Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof |
US10689464B2 (en) | 2015-03-09 | 2020-06-23 | Contipro A.S. | Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof |
US10759878B2 (en) | 2015-06-15 | 2020-09-01 | Contipro A.S. | Method of crosslinking of polysaccharides using photoremovable protecting groups |
US10973680B2 (en) | 2012-01-04 | 2021-04-13 | Sight Sciences, Inc. | Controller for dry eye treatment systems |
US11141348B2 (en) | 2018-02-26 | 2021-10-12 | Olympic Ophthalmics, Inc. | Treatment methods using handheld devices for disorders |
US11285040B2 (en) | 2012-01-04 | 2022-03-29 | Sight Sciences, Inc. | Combination treatment systems |
US12233017B2 (en) | 2016-10-14 | 2025-02-25 | Olympic Ophthalmics, Inc. | Quiet handheld devices and methods for treatment of disorders |
US12257181B2 (en) | 2021-02-05 | 2025-03-25 | Sight Sciences, Inc. | Controller for dry eye treatment systems |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1687472A (en) * | 1927-07-22 | 1928-10-09 | Johnson & Johnson | Emergency applicator and method of producing it |
US2702780A (en) * | 1950-10-10 | 1955-02-22 | Phil Kalech | Measuring dispensing sheet for germicides and process of forming same |
US2703777A (en) * | 1950-05-02 | 1955-03-08 | Iso Sol Company Inc | Ophthalmological preparations and vehicles and method of making the same |
-
1960
- 1960-06-02 US US33510A patent/US3075527A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1687472A (en) * | 1927-07-22 | 1928-10-09 | Johnson & Johnson | Emergency applicator and method of producing it |
US2703777A (en) * | 1950-05-02 | 1955-03-08 | Iso Sol Company Inc | Ophthalmological preparations and vehicles and method of making the same |
US2702780A (en) * | 1950-10-10 | 1955-02-22 | Phil Kalech | Measuring dispensing sheet for germicides and process of forming same |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3678151A (en) * | 1969-07-25 | 1972-07-18 | Gugol Clini Tex Inc | Biological staining method |
US3863633A (en) * | 1971-06-04 | 1975-02-04 | Pharmacia Ab | Composition containing a substance showing a topical effect on the eye, and a method of preparing the same |
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US3870791A (en) * | 1972-04-24 | 1975-03-11 | Heskel M Haddad | Solid state ophthalmic medication delivery method |
US4540408A (en) * | 1981-04-30 | 1985-09-10 | Smith And Nephew Associated Companies Limited | Applicators for pharmacologically active agents, their preparation and use |
US4778457A (en) * | 1986-11-06 | 1988-10-18 | York Kenneth K | Disposable applicator |
US5928662A (en) * | 1996-07-31 | 1999-07-27 | Phillips; Andrew F. | Ocular drug delivery device |
US6159189A (en) * | 1998-08-12 | 2000-12-12 | Ocular Research Of Boston, Inc. | Method for instilling a controlled dose of fluid into the eye |
EP1104263A1 (en) * | 1998-08-12 | 2001-06-06 | Ocular Research of Boston, Inc. | Measurement of tear film break-up-time |
EP1104263A4 (en) * | 1998-08-12 | 2008-11-19 | Ocular Res Of Boston Inc | Measurement of tear film break-up-time |
WO2000069506A1 (en) * | 1999-05-18 | 2000-11-23 | Ocular Research Of Boston, Inc. | Method for instilling a controlled dose of fluid into the eye |
EP1332754A1 (en) * | 2002-01-31 | 2003-08-06 | Daniel Mojon | Material-releasing carrier |
US20030225381A1 (en) * | 2002-05-30 | 2003-12-04 | Van Dalen Johan T.W. | Apparatus and method for delivering controlled quantities of one or more agents to the eye |
US7018646B2 (en) | 2002-05-30 | 2006-03-28 | Van Dalen Johan T W | Apparatus and method for delivering controlled quantities of one or more agents to the eye |
EP1407732A1 (en) * | 2002-10-08 | 2004-04-14 | Michael Dr. Horstmann | Eye applicable device for secure dosage of systemic and topic medication |
US10772758B2 (en) | 2012-01-04 | 2020-09-15 | Sight Sciences, Inc. | Dry eye treatment apparatus and methods |
US9642743B2 (en) | 2012-01-04 | 2017-05-09 | Sight Sciences, Inc. | Methods for improving contact lens comfort |
US9724230B2 (en) * | 2012-01-04 | 2017-08-08 | Sight Sciences, Inc. | Dry eye treatment apparatus and methods |
US9844459B2 (en) | 2012-01-04 | 2017-12-19 | Sight Sciences, Inc. | Dry eye treatment systems |
US11285040B2 (en) | 2012-01-04 | 2022-03-29 | Sight Sciences, Inc. | Combination treatment systems |
US10973680B2 (en) | 2012-01-04 | 2021-04-13 | Sight Sciences, Inc. | Controller for dry eye treatment systems |
US10052226B2 (en) | 2012-01-04 | 2018-08-21 | Sight Sciences, Inc. | Dry eye treatment systems |
US10925765B2 (en) | 2012-01-04 | 2021-02-23 | Sight Sciences, Inc. | Dry eye treatment systems |
US9510972B2 (en) | 2012-01-04 | 2016-12-06 | Sight Sciences, Inc. | Dry eye treatment systems |
US9320645B2 (en) | 2013-05-29 | 2016-04-26 | Terry Glasser | Approach to administering ocular medication |
US10617711B2 (en) | 2014-06-30 | 2020-04-14 | Contipro A.S. | Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof |
US10689464B2 (en) | 2015-03-09 | 2020-06-23 | Contipro A.S. | Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof |
US10759878B2 (en) | 2015-06-15 | 2020-09-01 | Contipro A.S. | Method of crosslinking of polysaccharides using photoremovable protecting groups |
US10414832B2 (en) | 2015-06-26 | 2019-09-17 | Contipro A.S | Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof |
JP2018518514A (en) * | 2015-06-26 | 2018-07-12 | コンティプロ アクチオヴァ スポレチノスト | Ophthalmic pharmaceutical composition |
US10618984B2 (en) | 2016-06-27 | 2020-04-14 | Contipro A.S. | Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof |
EP3487480A4 (en) * | 2016-07-20 | 2019-07-24 | Ryan, Edwin | Eye drop applicator and method |
US20190183675A1 (en) * | 2016-07-20 | 2019-06-20 | Edwin Ryan | Eye drop applicator and method |
WO2018017873A1 (en) | 2016-07-20 | 2018-01-25 | Ryan Edwin | Eye drop applicator and method |
US12233017B2 (en) | 2016-10-14 | 2025-02-25 | Olympic Ophthalmics, Inc. | Quiet handheld devices and methods for treatment of disorders |
US11147735B2 (en) | 2018-02-26 | 2021-10-19 | Olympic Ophthalmics, Inc. | Therapeutic handheld devices for disorders |
US11147737B2 (en) | 2018-02-26 | 2021-10-19 | Olympic Ophthalmics, Inc. | Handheld device with motorized member for treatment of disorders |
US11147736B2 (en) | 2018-02-26 | 2021-10-19 | Olympic Ophthalmics, Inc. | Therapeutic handheld devices for disorders |
US11318066B2 (en) | 2018-02-26 | 2022-05-03 | Olympic Ophthalmics, Inc. | Handheld device with vibrational cantilever member for treatment of disorders |
US11801197B2 (en) | 2018-02-26 | 2023-10-31 | Olympic Ophthalmics, Inc. | Treatment methods using handheld devices for disorders |
US12016819B2 (en) | 2018-02-26 | 2024-06-25 | Olympic Ophthalmics, Inc. | Treatment methods using handheld devices for disorders |
US11141348B2 (en) | 2018-02-26 | 2021-10-12 | Olympic Ophthalmics, Inc. | Treatment methods using handheld devices for disorders |
US12257181B2 (en) | 2021-02-05 | 2025-03-25 | Sight Sciences, Inc. | Controller for dry eye treatment systems |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3075527A (en) | Sterile medicated strips | |
DE69728280T2 (en) | APPLICATOR FOR CHLOROHEXIDING LUCONATE (CHG) - SINGLE DOSE WITH EXTENDED DURABILITY | |
US3948265A (en) | Medicated applicator | |
US4437567A (en) | Sterile package and method of making | |
US3287222A (en) | Method for preparation of synthetic fiber medical dressing impregnated with therapeutic | |
US2102858A (en) | Capsule for storing fluids | |
US5702035A (en) | Slender tubular container with opening and closing means | |
US2760630A (en) | Foil covered ampoule | |
US4486488A (en) | Composition for the production of bandages, bandages produced therewith and method for the production thereof | |
US3043067A (en) | Suture package | |
US10974037B2 (en) | Device for the preparation and application of a medical substance | |
EP0081438A2 (en) | Adhesive bandage | |
GB669265A (en) | Improvements in method and means for preserving small doses of biological and like liquids | |
US3194237A (en) | Pronged vaccinating and testing needle | |
US2595606A (en) | Surgical dressing | |
CA2642435A1 (en) | Sterile kit containing silicone gel for stereotaxy | |
US3474789A (en) | Flexible ampoule | |
US2128701A (en) | Method and apparatus for preserving sterile suture material for medicinal purposes ready for use | |
US3086647A (en) | Dispensing package | |
WO1981000196A1 (en) | Disposable swab articles and other like packages | |
PT645081E (en) | DEVICE FOR CARRYING OUT INSECTICIDAL TREATMENTS AND USING IT IN A ROOM | |
US1309201A (en) | Planoqeaph co | |
US4357935A (en) | Dry method of making a dry socket dressing | |
JPH01305043A (en) | Alcohol having suppressed evaporation tendency | |
US3857677A (en) | Method of sterile packaging |